شنبه 29 اردیبهشت 1403
دوره 9، شماره 3 - ( 4-1402 )
جلد 9 شماره 3 صفحات 199-193 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Soltani M, Salimnia N, Nahayati M A, Payere M. Case Series of Cerebral Venous Sinus Thrombosis After COVID-19 Vaccination. Caspian J Neurol Sci 2023; 9 (3) :193-199
URL: http://cjns.gums.ac.ir/article-1-644-fa.html
URL: http://cjns.gums.ac.ir/article-1-644-fa.html
Case Series of Cerebral Venous Sinus Thrombosis After COVID-19 Vaccination. مجله علوم اعصاب کاسپین. 1402; 9 (3) :193-199
چکیده: (442 مشاهده)
Background: While care for COVID-19 patients has improved with clinical experience, there
remains a critical and unmet medical need for vaccines suitable to help or alleviate COVID-19
infections during the pandemic. Although the available vaccines have some benign autoimmune
side effects, such as mild thrombocytopenia, in rare cases, the side effects, such as central vein
thrombosis, severe thrombocytopenia, and intracranial hemorrhage, are life-threatening.
Case Presentation: We report 3 female patients (19, 24, and 43 years old) who developed cerebral
venous sinus thrombosis (CVST) after the AstraZeneca ChAdOx1-S COVID-19 vaccination.
Despite medical and surgical treatment, they finally became brain dead.
Conclusion: Medical professionals should know the manifestations and diagnostic methods of
CVST after the COVID-19 vaccination and how to properly treat and manage it.
remains a critical and unmet medical need for vaccines suitable to help or alleviate COVID-19
infections during the pandemic. Although the available vaccines have some benign autoimmune
side effects, such as mild thrombocytopenia, in rare cases, the side effects, such as central vein
thrombosis, severe thrombocytopenia, and intracranial hemorrhage, are life-threatening.
Case Presentation: We report 3 female patients (19, 24, and 43 years old) who developed cerebral
venous sinus thrombosis (CVST) after the AstraZeneca ChAdOx1-S COVID-19 vaccination.
Despite medical and surgical treatment, they finally became brain dead.
Conclusion: Medical professionals should know the manifestations and diagnostic methods of
CVST after the COVID-19 vaccination and how to properly treat and manage it.
| بازنشر اطلاعات | |
 | این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
